Edition:
India

Aptevo Therapeutics Inc (APVO.OQ)

APVO.OQ on NASDAQ Stock Exchange Global Select Market

5.54USD
22 Jun 2018
Change (% chg)

$-0.11 (-1.95%)
Prev Close
$5.65
Open
$5.60
Day's High
$5.97
Day's Low
$5.49
Volume
85,663
Avg. Vol
31,688
52-wk High
$6.30
52-wk Low
$1.18

Chart for

About

Aptevo Therapeutics Inc. is a biotechnology company. The Company is focused on oncology and hematology therapeutics. The Company is engaged in the discovery, development, commercialization and sale of oncology and hematology therapeutics. The Company's technology is the ADAPTIR (modular protein technology) platform. The Company... (more)

Overall

Beta: --
Market Cap(Mil.): $57.83
Shares Outstanding(Mil.): 21.42
Dividend: --
Yield (%): --

Financials

BRIEF-Aptevo Therapeutics Begins Patient Dosing In Phase 2 Clinical Trial Of Otlertuzumab In Peripheral T-Cell Lymphoma

* APTEVO THERAPEUTICS BEGINS PATIENT DOSING IN PHASE 2 CLINICAL TRIAL OF OTLERTUZUMAB IN PERIPHERAL T-CELL LYMPHOMA Source text for Eikon: Further company coverage:

08 Jan 2018

Earnings vs. Estimates